AniBiome
Uses AI-driven diagnostics to formulate personalized fermented bioactives targeting gut microbiome optimization, inflammation reduction, and long-term metabolic health.
Portfolio
We invest directly in frontier companies and partner with specialist managers whose edge we could not build in-house.
13 of 22 companies and 7 of 10 fund positions named belowSelected investments
Direct positions in frontier technology companies, from pre-seed research bets through growth.
13 of 13 entries
A decentralized peer-to-peer marketplace for AI, using blockchain to incentivize AI experts worldwide to collaboratively train and scale machine learning models — democratizing access to AI.
Renewal Bio’s breakthrough technology turns any skin cell into a human embryo, making egg-free human cloning a reality and opening the door to generate custom stem cells and grow human organs like never before.
Pioneering data centers in space, leveraging space’s natural vacuum cooling and unhindered solar energy to deliver sustainable, resilient AWS-like cloud infrastructure from orbit.
VitalAudio has developed a revolutionary technology that provides your heart rate, blood pressure, and many other biomarkers in real time, from just a 10-second call or voice recording.
Backed by OpenAI CEO Sam Altman, Retro Biosciences is a cutting-edge biotechnology company leveraging proprietary AI models to discover breakthroughs that can increase healthy human lifespan by a decade.
Uses AI-driven diagnostics to formulate personalized fermented bioactives targeting gut microbiome optimization, inflammation reduction, and long-term metabolic health.
Designing purpose-built hardware for AI inference, engineered to dramatically accelerate machine learning workloads with superior speed, power efficiency, and production performance.
Building foundation models for physical machines, bridging AI and real-world action to enable robots to learn, adapt, and interact with complex environments with unprecedented dexterity.
Co-founded and co-led by Jeff Bezos, Project Prometheus is building an “artificial general engineer” — AI for the physical world that automates engineering and manufacturing across computers, automobiles, aerospace, and drug design.
Founded by ex-OpenAI research VP Jerry Tworek, Core Automation is a frontier AI lab reinventing model training through continual learning and new algorithms beyond scaling — aiming to build the most automated AI lab in the world.
Led by co-founder and CEO Garth Sheldon-Coulson, Panthalassa deploys autonomous wave-powered platforms on the open ocean, converting wave energy into terawatt-scale electricity and offshore compute for AI workloads.
Co-founded by Paco Chan, Farmio is a Singapore-based B2B platform bringing AI-driven automation to the food supply chain, replacing manual ordering and logistics workflows for retailers and F&B businesses across Southeast Asia.
A proactive personal intelligence AI with its own bespoke hardware. By interacting through sight, speech, and hearing while building persistent memory, the multi-modal platform acts as a true agentic companion that thinks alongside or ahead of the user.
LP positions with specialist managers whose access and judgment extend our reach beyond what one office can cover.
A specialized venture fund backing companies at the intersection of aging science, biotech, and longevity therapeutics — targeting breakthrough interventions that extend healthy human lifespan.
A data-driven venture fund leveraging proprietary machine learning models to identify and invest in high-potential early-stage technology companies before traditional investors.
An early-stage venture capital firm backing ambitious founders building transformative companies across enterprise software, fintech, and frontier technology sectors.
An early-stage investment firm with a strong track record of partnering with visionary founders across AI and technology verticals to accelerate scale and market impact.
An elite live-in residency and accelerator in San Francisco for repeat founders, providing 12 weeks of deep, distraction-free focus to build transformative technology companies — often called the “monastery for founders.”
A longevity-focused venture capital fund investing in the most promising scientific and technological breakthroughs in aging biology, rejuvenation medicine, and life extension.
A pre-seed and seed-stage venture fund backing exceptional immigrant founders building technology companies in the United States.
Managed and in-house strategies that hold liquid exposure to the same technology shifts we back privately.
A hedge fund providing managed exposure to the Bittensor ecosystem via subnet alpha tokens, capitalizing on the convergence of decentralized AI and digital assets as the network scales.
A novel quant strategy developed in-house that uses AI to help extract alpha from predicting probabilities in prediction markets.
The portfolio runs to 22 companies and 10 fund positions; the 13 and 7 named here are those we disclose. The list may include historical relationships. Nothing here is an offer to sell or a solicitation of an offer to buy any security.
Let’s compare notes
We welcome introductions from founders and managers with a distinct point of view — including on companies already in this list.
hello@inventive.capital